No Data
CLOVER BIO-B: 2024 Annual Report
Three Leaf Clover Biotech-B (02197.HK) granted 5.964 million stock options and 9.0165 million restricted share units.
On April 2, Glonghui reported that Clover Biologics-B (02197.HK) announced that the Board of Directors declared on April 2, 2025, that the company granted a total of 5,964,000 stock options and 9,016,500 restricted stock units to several eligible participants in accordance with the terms of the post-IPO stock option plan and the restricted stock unit plan.
Clover Biotech-B (02197) announced its annual performance, with a loss of 0.903 billion yuan for the year.
Clover Bio-B (02197) announced its annual results for the year ending December 31, 2024, with revenues of 3841...
Express News | Clover Biopharmaceuticals FY Net Income RMB -903.4 Million
Express News | Clover Biopharmaceuticals FY Revenue RMB 11.6 Million
CLOVER BIO-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2024
